[ACL] YoY Quarter Result on 31-Mar-2021 [#Q3]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
30-Mar-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q3]
Profit Trend
QoQ- -97.11%
YoY- -92.02%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 179,550 168,380 228,802 164,399 115,435 11.66%
PBT 14,280 7,777 34,978 2,690 15,515 -2.05%
Tax 4,696 2,497 10,921 1,032 5,163 -2.34%
NP 9,491 5,240 24,015 1,650 20,678 -17.67%
Tax Rate -32.88% -32.11% -31.22% -38.35% -33.27% -
Total Cost 170,059 163,140 204,787 162,749 94,758 15.73%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin 5.29 3.11 10.50 1.00 17.91 -26.26%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS 0.05 0.03 0.12 0.01 0.10 -15.90%
EPS Diluted 0.05 0.03 0.12 0.01 0.10 -15.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.